| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | 0 | 35.330 | 55.472 | 45.461 | 39.002 |
| Total Income - EUR | - | - | - | - | - | 0 | 35.330 | 66.356 | 49.615 | 41.756 |
| Total Expenses - EUR | - | - | - | - | - | 7 | 42.047 | 52.519 | 48.905 | 49.930 |
| Gross Profit/Loss - EUR | - | - | - | - | - | -7 | -6.716 | 13.838 | 710 | -8.174 |
| Net Profit/Loss - EUR | - | - | - | - | - | -7 | -6.850 | 13.355 | 323 | -8.564 |
| Employees | - | - | - | - | - | 0 | 2 | 2 | 2 | 2 |
Check the financial reports for the company - Simtov Pharma Spa S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | 27 | 694 | 399 | 101 | 0 |
| Current Assets | - | - | - | - | - | 34 | 16.717 | 32.268 | 25.017 | 16.333 |
| Inventories | - | - | - | - | - | 0 | 8.663 | 14.325 | 7.116 | 6.912 |
| Receivables | - | - | - | - | - | 0 | 4.881 | 12.154 | 8.741 | 6.915 |
| Cash | - | - | - | - | - | 34 | 3.173 | 5.789 | 9.160 | 2.506 |
| Shareholders Funds | - | - | - | - | - | 34 | -6.816 | 6.517 | 5.002 | -3.590 |
| Social Capital | - | - | - | - | - | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | - | 27 | 24.228 | 26.149 | 20.117 | 19.923 |
| Income in Advance | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4645 - 4645" | |||||||||
| CAEN Financial Year |
4645
|
|||||||||
Comments - Simtov Pharma Spa S.r.l.